CDT Equity Stock (NASDAQ:CDT)

Revenue Ownership Financials Chart

Previous Close

$3.27

52W Range

$2.92 - $4.20K

50D Avg

$7.92

200D Avg

$263.93

Market Cap

$1.49M

Avg Vol (3M)

$713.31K

Beta

1.46

Div Yield

-

CDT Company Profile

Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Mar 28, 2022

Website

CDT Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 24
Automation Solutions	$1.32B

Fiscal year ends in Dec 25 | Currency in USD

CDT Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	$2.72B	-	-
Operating Income	$315.69M	$-15.42M	$-5.26M
Net Income	$237.52M	$-17.80M	$-535.00K
EBITDA	$315.69M	$-15.84M	$3.05M
Basic EPS	$6.00	$-20.53	$-3.60
Diluted EPS	$5.91	$-20.53	$-3.60

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

Ticker	Company
XAGE	Longevity Health Holdings Inc.
COCH	Envoy Medical, Inc.
ZVSA	ZyVersa Therapeutics, Inc.
PTPI	Petros Pharmaceuticals, Inc.
CCM	Concord Medical Services Holdings Limited
NIVF	NewGenIvf Group Limited
ENVB	Enveric Biosciences, Inc.